1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial, 2023, Krogvold et al

Discussion in 'Other health news and research' started by Midnattsol, Oct 4, 2023.

  1. Midnattsol

    Midnattsol Moderator Staff Member

    Messages:
    3,592
    Abstract
    Previous studies showed a low-grade enterovirus infection in the pancreatic islets of patients with newly diagnosed type 1 diabetes (T1D). In the Diabetes Virus Detection (DiViD) Intervention, a phase 2, placebo-controlled, randomized, parallel group, double-blind trial, 96 children and adolescents (aged 6–15 years) with new-onset T1D received antiviral treatment with pleconaril and ribavirin (n = 47) or placebo (n = 49) for 6 months, with the aim of preserving β cell function. The primary endpoint was the mean stimulated C-peptide area under the curve (AUC) 12 months after the initiation of treatment (less than 3 weeks after diagnosis) using a mixed linear model. The model used longitudinal log-transformed serum C-peptide AUCs at baseline, at 3 months, 6 months and 1 year. The primary endpoint was met with the serum C-peptide AUC being higher in the pleconaril and ribavirin treatment group compared to the placebo group at 12 months (average marginal effect = 0.057 in the linear mixed model; 95% confidence interval = 0.004–0.11, P = 0.037). The treatment was well tolerated. The results show that antiviral treatment may preserve residual insulin production in children and adolescent with new-onset T1D. This provides a rationale for further evaluating antiviral strategies in the prevention and treatment of T1D. European Union Drug Regulating Authorities Clinical Trials identifier: 2015-003350-41.
     
  2. Midnattsol

    Midnattsol Moderator Staff Member

    Messages:
    3,592
    Peter Trewhitt likes this.
  3. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    13,444
    Location:
    London, UK
    I don't understand why they are reporting average marginal effect when a straight comparison of AUC values would seem to be more intelligible. I have no idea what the average marginal effect means and if the p value is 0.037 it is clearly not a very obvious effect.
     
    Peter Trewhitt, shak8 and FMMM1 like this.

Share This Page